CLINICAL_TRIALS
trial_result
· 2025-08-01
Clinical Trial Update: Study to Assess the Effects of PTC857 Treatment in Participants With Amyotrophic Lateral Sclerosis ALS [Phase 2]
Summary
A Phase 2 study of PTC857 in amyotrophic lateral sclerosis was terminated, with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: PTC Therapeutics | Conditions: Amyotrophic Lateral Sclerosis | Phase 2 | Status: TERMINATED | Results posted: 2025-08-01